Cargando…

Cancer Prevention II

More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK)....

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Senn, Hans-Jörg (Editor ), Kapp, Ursula (Editor ), Otto, Florian (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2009.
Edición:1st ed. 2009.
Colección:Recent Results in Cancer Research, 181
Temas:
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Cancer Prevention and Health Politics
  • Do We Make Optimal Use of the Potential of Cancer Prevention?
  • Predictors of Successful Cancer Prevention Programs
  • Cancer Prevenpinon in the Developing World: Mission Impossible?
  • Is Cancer Prevention Ever Going to Be Profitable?
  • Cancer Prevention: The Scientific-Epidemiological Base
  • Energy Metabolism, Cancer Risk, and Cancer Prevention
  • Promises and Limitations of Biomarkers
  • Cancer Prevention, Tobacco and Nutrition
  • The EPIC Study: An Update
  • Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype.
  • Retinoids and Breast Cancer Prevention
  • Cancer Prevention, Genetics and Vaccines
  • Cancer Prevention by Vaccination Against Hepatitis B
  • Cancer Prevention and Target Organs I: Breast Cancer
  • Energy Restriction for Breast Cancer Prevention
  • The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer
  • Prevention of ER-Negative Breast Cancer
  • EHxoorgmeonnoeuss, aMnadmEmndooggraepnhoiucs Density and Breast Cancer Risk: Can Mammographic Density Be Considered an Intermediate Marker of Risk?
  • Cancer Prevention and Target Organs II: Cancer of the Digestive Tract
  • Chemoprevention of Oesophageal Cancer and the AspECT Trial
  • Cancer Prevention and Target Organs III: Prostate Cancer
  • Review of Diagnostic Markers for Prostate Cancer 16
  • Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Prevention
  • Prostate Cancer Prevention by Short-Term Anti-androgens: The Rationale Behind Design of Pilot Studies
  • Cancer Prevention and Target Organs III: Prostate Cancer
  • Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
  • Aspirin and NSAIDs in Cancer Prevention: Attempts at an International Consensus
  • Pharmacologic Effects of NSAIDs and Implications for the Risks and Benefits of Long-Term Prophylactic Use of Aspirin to Prevent Cancer
  • Aspirin and NSAIDs for the Prevention of Colorectal Cancer
  • Aspirin and Cancer Risk: A Summary Review to 2007.